Viewing entries tagged
Prostate cancer

Screening for Prostate Cancer Can Be Risky Business

Comment

Screening for Prostate Cancer Can Be Risky Business

The majority of radical treatment decisions are made on the basis and results of PSA testing. PSA or Prostate-Specific Antigen, is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in the blood. Due to the dangers of overtreatment some experts have proposed forgoing PSAtesting altogether. However, this attitude is like throwing the baby out with the bathwater, since early diagnosis and treatment of high-grade prostate cancer unquestionably improves survival and quality of life.  

Comment

Adjuvant Hormone Blockade (HB) after Surgery for Men with Aggressive Disease

Comment

Adjuvant Hormone Blockade (HB) after Surgery for Men with Aggressive Disease

The term "adjuvant" means treatment “added to” the primary or initial treatment. When the primary treatment is surgery, even when all detectable disease is removed, there remains a statistical risk that the cancer will return due to microscopic cancer cells left behind. Men with high-risk features such as extra-prostatic extension or high Gleason score face a higher risk of recurrence.

Comment